Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
appellant, appendix, area, bachelor, Baxter, Biology, Cancer, Castillo, certify, ChAd, Chair, Chicago, Chief, Citizenship, color, Committee, description, developmental, director, disposal, disposition, disqualify, Division, DNX, employed, enacted, entirety, entitled, Exhibit, family, half, hand, hereto, Kimeragen, Kirsten, Kumar, long, longer, manner, Marna, MBA, microbiology, Molecular, Nextran, Onconova, opening, Panjab, physical, power, Prabhavathi, President, Princeton, Ramesh, reconstituted, reconstitution, recoverable, regime, Regulation, representation, reserved, RIA, role, salary, Squibb, subset, TEA, text, trained, undiscounted, Valigen, vector, vote, voting, weekly, white, Whittington, writing, wrote
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view